Mad Money

Lightning Round: Qualcomm, GenCorp & more

Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

Qualcomm (QCOM): It's a buy, said Cramer. Wall Street is addicted to this stock. I'd buy half a position now and the other half on negative news.

PTC Therapeutics (PTCT): I think biotechs deserve a long hard look after Merck acquired hepatitis C maker Idenix for $24.50 per share, more than three times Idenix's Friday closing price of $7.23, Cramer said.

Getty Images

GenCorp (GY): I'm a buyer, said Cramer. It's a good situation.

Freeport-McMoRan (FCX): I'm not a fan, said Cramer. In the space I'd rather own Alcoa.



Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com